(Q35767490)

10 August 2017

Hypertension and the elderly: more than just blood pressure control (English)

1 reference

10 August 2017

Lawrence Baruch

1

1 reference

PubMed ID

15133407

10 August 2017

language of work or name

1 reference

1 May 2004

1 reference

Journal of Clinical Hypertension

10 August 2017

1 reference

10 August 2017

6

1 reference

10 August 2017

249-255

1 reference

10 August 2017

5

1 reference

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

10 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Factors influencing arterial stiffness in systolic hypertension in the elderly: role of sodium and the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Systolic hypertension as a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Effect of amlodipine on systolic blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Efficacy of valsartan in patients aged > or =65 years with systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Benefits of antihypertensive pharmacologic therapy and blood pressure reduction in outcome trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

Differential Control of Systolic and Diastolic Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2004.03307.X

10.1111/J.1524-6175.2004.03307.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15133407